TATA MEDICAL CENTER BIOREPOSITORY (TiMBR), India

Registration Status: Completed

Objective: TiMBR (Tata Medical Center Biorepository), established in 2013, has evolved into an objective-driven biobanking facility, optimizing sample utilization and refining protocols for enhanced efficiency. With a repository of approximately 95,000 biological specimens (plasma, tissue, nucleic acids, viable cells, and organoids), TiMBR supports over 25 research projects and clinical trials across eight departments at Tata Medical Center, New Town, West Bengal, India. Specializing in hematological malignancies and solid tumors, particularly Gall Bladder and Breast Cancer, TiMBR maintains a robust collection of high-quality samples, including viable leukemic cells and tumor organoids. Rigorous preservation and post-retrieval validation procedures ensure the integrity of these specimens for impactful translational research.

Registered Biobank Name	TATA MEDICAL CENTER BIOREPOSITORY (TiMBR)
Biobank Leader	ABHIRUPA KAR
Country	India
Email for biobank inquiries	abhirupa.kar@ttcrc.tmckolkata.org
Principal Investigator	DR. SAUGATA SEN, DR. MAYUR PARIHAR
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).